Who actually executed the Hinge Health (HNGE) share sales in this Form 4?

The sales were executed by Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P., together called the Bessemer Funds. These investment funds, not Robinson Elliott personally, sold the Hinge Health Class A Common Stock disclosed in the Form 4 footnotes.

Bessemer funds tied to Hinge Health (HNGE) director sell Class A shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hinge Health, Inc. director Robinson Elliott filed a Form 4 reporting open-market sales of Class A Common Stock by funds affiliated with Bessemer Venture Partners. On June 1, 2026, Bessemer Venture Partners X L.P. sold 51,580 shares and Bessemer Venture Partners X Institutional L.P. sold 48,420 shares at a weighted average price of $61.08, executed in multiple trades between $60.82 and $61.44. On June 2, 2026, the same funds sold 10,121 and 9,500 shares, respectively, at a weighted average price of $60.34, in trades between $60.00 and $60.74. Elliott is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in these holdings and expressly disclaims beneficial ownership beyond any indirect pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Robinson Elliott

Role null

Sold 0 shs ($0.00)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	0	$0.00	--
Sale	Class A Common Stock	0	$0.00	--

Holdings After Transaction: Class A Common Stock — 0 shares (Indirect, See footnote)

Footnotes (1)

On June 1, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 51,580 and 48,420 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $61.08. These shares were sold in multiple transactions at prices ranging from $60.82 to $61.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. On June 2, 2026, BVP X and BVP X Inst sold 10,121 and 9,500 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $60.34. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

Key Figures

BVP X June 1 sale: 51,580 shares at $61.08 BVP X Inst June 1 sale: 48,420 shares at $61.08 BVP X June 2 sale: 10,121 shares at $60.34 +3 more

6 metrics

BVP X June 1 sale 51,580 shares at $61.08 Class A Common Stock sold June 1, 2026

BVP X Inst June 1 sale 48,420 shares at $61.08 Class A Common Stock sold June 1, 2026

BVP X June 2 sale 10,121 shares at $60.34 Class A Common Stock sold June 2, 2026

BVP X Inst June 2 sale 9,500 shares at $60.34 Class A Common Stock sold June 2, 2026

June 1 price range $60.82–$61.44 Trade price range for June 1, 2026 sales

June 2 price range $60.00–$60.74 Trade price range for June 2, 2026 sales

Key Terms

Class A Common Stock, weighted average price, indirect, passive economic interest, beneficial ownership, +1 more

5 terms

Class A Common Stock financial

"shares of Class A Common Stock of the Issuer"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

weighted average price financial

"sold ... shares ... at a weighted average price of $61.08"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

indirect, passive economic interest financial

"has an indirect, passive economic interest in the shares held"

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership of the securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of his pecuniary interest, if any"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/03/2026 - 05:31 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robinson Elliott

(Last)

(First)

(Middle)

C/O BESSEMER VENTURE PARTNERS

1865 PALMER AVENUE, SUITE 104

(Street)

LARCHMONT

NEW YORK

10538

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/01/2026		S		0⁽¹⁾	D	$0	0	I	See footnote⁽¹⁾⁽³⁾
Class A Common Stock	06/02/2026		S		0⁽¹⁾	D	$0	0	I	See footnote⁽²⁾⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On June 1, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 51,580 and 48,420 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $61.08. These shares were sold in multiple transactions at prices ranging from $60.82 to $61.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. On June 2, 2026, BVP X and BVP X Inst sold 10,121 and 9,500 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $60.34. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.

	/s/ Augie Wilkinson, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HNGE report in this Form 4?

The filing reports open-market sales of Hinge Health Class A Common Stock by Bessemer Venture Partners funds associated with director Robinson Elliott. These sales occurred on June 1 and June 2, 2026, and are disclosed as indirect transactions through those investment funds, not personal trades.

How many Hinge Health (HNGE) shares were sold on June 1, 2026?

On June 1, 2026, Bessemer Venture Partners X L.P. sold 51,580 Hinge Health shares and Bessemer Venture Partners X Institutional L.P. sold 48,420 shares. All were Class A Common Stock, executed in multiple trades at prices ranging from $60.82 to $61.44 per share.

What prices were received for Hinge Health (HNGE) shares sold on June 2, 2026?

On June 2, 2026, Bessemer Venture Partners X L.P. sold 10,121 shares and Bessemer Venture Partners X Institutional L.P. sold 9,500 shares. The weighted average price was $60.34 per share, with individual trades priced between $60.00 and $60.74.

Does Robinson Elliott personally own the Hinge Health (HNGE) shares sold?

The filing states Robinson Elliott is a partner at Bessemer Venture Partners with an indirect, passive economic interest in the Bessemer funds’ Hinge Health shares. He disclaims beneficial ownership of the securities except to the extent of any indirect pecuniary interest in those funds.